- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Intercept Pharmaceuticals Inc+ Add to Watchlist
ICPT:US34.1600 USD 1.2600 3.83%
As of 14:54:25 ET on 05/23/2013.
Company Profile for Intercept Pharmaceuticals Inc (ICPT)
Intercept Pharmaceuticals Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.
Intercept Pharmaceuticals Inc
Key Executives for Intercept Pharmaceuticals Inc (ICPT)
|Mark PruzanskiPresident/CEO/Co-Founder||Barbara DuncanCFO/Treasurer/Secretary|
|Luciano AdoriniChief Scientific Officer||Daniel P ReganChief Commercial Officer|
|David ShapiroExec VP:Dev/Chief Medical Ofcr|